Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase. [electronic resource]
Producer: 19970304Description: 2235-45 p. digitalISSN:- 1043-0342
- Animals
- B-Lymphocytes -- drug effects
- Cell Line, Transformed
- Cytosine Deaminase
- Escherichia coli -- enzymology
- Female
- Flucytosine -- pharmacology
- Ganciclovir -- pharmacology
- Gene Transfer Techniques
- Genetic Therapy -- methods
- Genetic Vectors -- genetics
- Herpesvirus 4, Human
- Humans
- Lymphoma, B-Cell -- therapy
- Mice
- Mice, SCID
- Nucleoside Deaminases -- genetics
- Prodrugs -- pharmacology
- Retroviridae -- genetics
- Simplexvirus -- enzymology
- Thymidine Kinase -- genetics
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.